Lv3
280 积分 2021-11-17 加入
Niraparib: A Review in Ovarian Cancer
1个月前
已完结
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
1个月前
已完结
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
1个月前
已完结
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
1个月前
已完结
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
1个月前
已完结
Sequential single agents as first-line chemotherapy for ovarian cancer: a strategy derived from the results of GOG-132
1个月前
已完结
Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole
2个月前
已完结
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature
2个月前
已完结
Contraception and the risk of ectopic pregnancy: A meta-analysis
2个月前
已完结
Bilateral functioning uterine anlagen with the Rokitansky-Mayer-Kuster-Hauser syndrome
2个月前
已关闭
皖公网安备34019202002308
